Date: 2016-08-23
Type of information: Construction of new premises
Compound: Pfizer Global Biotechnology Center in China
Company: Jacobs Engineering Group (USA - CA) Pfizer (USA - NY)
Therapeutic area: Technology - Services
Type agreement: services contract construction of new premises
Action mechanism:
Disease:
Details: * On August 23, 2016, Jacobs Engineering Group announced it was awarded a contract to lead design and provide engineering services, procurement and construction support for Pfizer, Inc.’s new $350 million Global Biotechnology Center investment in the Hangzhou Economic Development Area in China . Under the terms of the agreement, Jacobs is responsible for developing the overall site design, which includes aseptic fill/finish, drug substance and central utility buildings; a quality laboratory; administration offices; and a warehouse. The facility is being built to produce monoclonal antibodies and also serve as a process development and clinical supply site for biologic medicines in China .The facility is expected to be complete in 2018.
Financial terms:
Latest news:
